Abstract
Knee pain is a prevalent condition that can significantly impact individuals’ quality of life. Topical analgesics have emerged as a potential noninvasive treatment option for knee pain. This systematic review aimed to assess the effectiveness and safety of topical analgesics in managing knee pain. A systematic literature search was conducted in electronic databases (PubMed, Embase, and Cochrane Library) up to May 25, 2023. Studies investigating the topical application of analgesics for knee pain were included. The outcomes of interest encompassed pain relief, functional improvement, adverse events, and patient satisfaction. Six studies met the inclusion criteria and were incorporated into the systematic review. These studies evaluated various topical analgesics, including nonsteroidal anti-inflammatory drugs capsaicin, lidocaine, and salicylates. Most of the studies were randomized controlled trials, whereas some were prospective cohort studies. The available evidence suggests that topical application of analgesics may be a viable treatment option for knee pain. However, further research is necessary to establish optimal treatment protocols, evaluate long-term efficacy, and conduct head-to-head comparisons of different topical analgesics. Standardization of outcome measures and study designs would facilitate better comparisons across studies. Additionally, future research should focus on assessing the cost-effectiveness and patient preferences related to topical analgesics for managing knee pain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.